Independent UK medicine guidance
Mounjaro and gastroparesis: delayed stomach emptying, warning signs and who should be cautious
Mounjaro (tirzepatide) works partly by slowing how fast the stomach empties. For most people that means fullness and some nausea in the early weeks. Gastroparesis is the medical name for a stomach that empties abnormally slowly all the time, and the UK leaflet asks anyone who already has severe digestion problems or severe gastroparesis to talk to their doctor before using Mounjaro. This guide explains the difference between expected slowing and a problem, and what the warning signs are.
Key facts
- The leaflet says to talk to your doctor, pharmacist or nurse before using Mounjaro if you have severe problems with food digestion or food remaining in your stomach longer than normal, including severe gastroparesis.[1]
- The SmPC notes that tirzepatide has not been studied in people with severe gastrointestinal disease, including severe gastroparesis, and should be used with caution in them.[2] Delayed gastric emptying itself is listed as an uncommon side effect.[2]
- Slower emptying is expected in everyone on tirzepatide; it is part of how the medicine reduces appetite and is greatest at the start of treatment.[2]
- Ordinary fullness, bloating and early nausea are common and usually settle. Persistent vomiting of food eaten hours earlier is not ordinary and needs assessment.
- Slower emptying also matters before surgery under anaesthetic; tell the surgical team you are on Mounjaro.[2]
Expected slowing versus a problem
| Expected on tirzepatide | Needs assessment |
|---|---|
| Feeling full quickly and staying full for hours | Feeling full after a few mouthfuls for weeks, with weight dropping far faster than planned |
| Nausea in the first weeks and after dose increases, easing at a steady dose | Nausea that gets worse at a steady dose, or vomiting most days |
| Bloating and burping after a large meal | Vomiting undigested food eaten many hours earlier |
| Mild cramping that passes | Severe or persistent stomach pain, with or without vomiting: leaflet says stop and seek urgent help[1] |
| Reflux after eating late | Difficulty swallowing, or reflux that does not respond to the usual measures |
The table cannot diagnose gastroparesis, which needs a clinician and sometimes a stomach-emptying test. It separates what the leaflet expects from what it does not.
If you already have gastroparesis or severe digestive disease
Tell your prescriber before starting, or now if you did not. The SmPC says tirzepatide has not been studied in patients with severe gastrointestinal disease, including severe gastroparesis, and should be used with caution in these patients.[2] That is a caution rather than a ban, and it includes gastroparesis from long-standing diabetes. An online questionnaire is only as good as the answers it gets; if you skipped that box, correct it.
Milder reflux, indigestion or irritable bowel syndrome are not the same as severe disease, but they are still worth declaring because they change how side effects are interpreted.
Why slower emptying is part of the mechanism
Tirzepatide delays gastric emptying, and the SmPC notes the effect is greatest after the first dose and reduces with continued treatment.[2] That fits what people describe: the fullest, queasiest weeks are the first ones, and each dose increase brings a smaller echo. It also explains why large or fatty meals, which take longest to leave the stomach anyway, are the ones that cause trouble.
Two practical consequences follow. Oral medicines can be absorbed more slowly, which is why the leaflet gives specific advice about oral contraceptives.[1] And food may still be in the stomach at the time of a general anaesthetic, which is why surgical teams need to know you are on it.[2] See Mounjaro before surgery.
What helps day to day
- Small meals, eaten slowly, stopping at comfortably full
- Low fat and low fibre on bad days, since both slow emptying further; return fibre when things settle
- Soft and liquid foods when solid food will not go down: soups, smoothies, yoghurt
- Stay upright for an hour or two after eating
- Fluids in sips between meals
- Tell your prescriber before any dose increase if you are still struggling at the current dose
Common questions
Does Mounjaro cause gastroparesis?
Mounjaro slows stomach emptying in everyone as part of how it works, and the effect lessens over time. Delayed gastric emptying is listed as an uncommon side effect in the UK product information; gastroparesis as a lasting condition is not listed, and whether the medicine causes it in some people is still being monitored. Persistent vomiting of food eaten hours earlier should be assessed rather than assumed to be normal.
Can I take Mounjaro if I have gastroparesis?
The product information asks for caution in people with severe gastrointestinal disease including severe gastroparesis, because it has not been studied in them. That is a decision for your prescriber with your history in front of them, not a blanket no.
How long does Mounjaro slow digestion for?
The slowing is greatest after the first dose and reduces with continued treatment. Most people find the fullness and nausea of the early weeks ease at a steady dose, with a smaller return after each increase.
Does slow stomach emptying affect other medicines?
It can slow absorption of oral medicines. The leaflet gives specific advice for oral contraceptives; for anything with a narrow safety margin, ask your pharmacist.
Related guides
About this page. Monj is an independent information and price comparison service run by Medstack Ltd. It is not a pharmacy and does not prescribe, dispense or sell medicines. This page provides general information, not diagnosis or individual medical advice, and it does not diagnose gastroparesis. It has not been clinically reviewed; a named clinical reviewer will be added when one has approved it. Read our editorial and review policy and independence statement.
References
- Eli Lilly. Mounjaro KwikPen: Package leaflet, information for the patient (UK), revised August 2026, section 2. electronic medicines compendium. medicines.org.uk/emc/product/15481/pil. Accessed 6 September 2026.
- Eli Lilly. Mounjaro KwikPen: Summary of Product Characteristics (UK), sections 4.4, 4.5 and 5.1. electronic medicines compendium. medicines.org.uk/emc/product/15481/smpc. Accessed 6 September 2026.
- NHS. Gastroparesis. nhs.uk/conditions/gastroparesis. Accessed 6 September 2026.
Explore other side effects
Tap a point on the body to jump to that symptom, or choose from the full list below. The pink marker shows where you are now.
© 2026 Medstack Ltd. Written and published by Monj (monj.co.uk). You are welcome to link to this page or quote a short extract with a credit and a link. Republishing the text, page structure, safety-routing design or price data, in whole or in part, including to train or ground an automated system, is not permitted without written permission. See our independence statement and editorial and review policy.
